Select a Size
About This Item
CofA
current certificate can be downloaded
Quality Level
packaging
pk of 1 ea
extent of labeling
5.1% Carbon loading
parameter
600 bar max. pressure (8700 psi)
maximum temperature
60 °C (pH2/60; pH7/40)
column L × I.D.
150 mm × 2.1 mm
surface area
75 m2/g
matrix
superficially porous particle particle platform (Fused-Core®)
matrix active group
C18 bonding phase, dimethyloctadecylsilane and positively charged ligand
operating pH range
2-7
General description
Analysis Note
Legal Information
Still not finding the right product?
Explore all of our products under BIOshell A160 Peptide PCS-C18, 2.7 µm HPLC Column
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Accurate LC-MS-based analysis of GLP-1 agonist drug liraglutide in human plasma samples using BIOshell™ A160 Peptide PCS-C18 column.
LC-MS-based analysis of GLP-1 agonist drug semaglutide for detection of a key N-terminal impurity using BIOshell™ A160 Peptide PCS-C18 column.
LC-MS/MS analysis of GLP-1 agonist drug liraglutide for identification of N-terminal cyclization impurity using BIOshell™ A160 Peptide PCS-C18 column.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 50659-U | 04065270862136 |